About
Kaiser Bio provides in vivo and in vitro efficacy evaluation services and customized consulting focused on drug candidates targeting neurodegenerative diseases such as dementia for pharmaceutical and biotech companies.
Explore Kaiser Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.